Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A.
American National Red Cross, Washington, DC, United States
Search 3 grants from Todd Hembrough
Search grants from American National Red Cross
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer
Harvard Clinical and Translational Science Center
Development of A National Public Health Information Infrastructure
Transforming Genes and Immunological Tumor Regression
Clinical Trial of Inhaled Steroids in Copd
Recently added grants:
Mentoring Patient-Oriented Research to Prevent Injury in Older Adults
A Dyadic Approach to Perinatal Depression Treatment in Primary Care
Bruins in Genomics: Dental, Oral & Craniofacial Research Training Program (BIG DOC)
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics
Investigating whole-body innate immune activation in Alzheimer's disease using PET imaging and immune profiling
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL009910-01
Application #
2521259
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1998-05-30
Project End
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Related projects
NIH 2000
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
$21,616
NIH 1999
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
NIH 1998
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
Publications
Hembrough, T A; Ruiz, J F; Papathanassiu, A E et al.
(2001)
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor.
J Biol Chem 276:12241-8
Comments
Be the first to comment on Todd Hembrough's grant